Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
30m agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
31m agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
31m agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
31m agoFirst Quantum Minerals Reports First Quarter 2026 Results
31m agoDistrict Metals Announces $10 Million Private Placement Financing
Rallybio Corp logo

Rallybio Corp

About

Rallybio Corp (NASDAQ:RLYB) — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 2 2026
Rallybio Corporation and Candid Therapeutics Announce Merger Agreement
Feb 17 2026
Rallybio Announces Positive Data for RLYB116 Phase 1 Study Demonstrating Complete and Sustained Inhibition of Terminal Complement
Feb 3 2026
Rallybio Announces Reverse Stock Split of Common Stock
Nov 6 2025
Rallybio Reports Third Quarter 2025 Financial Results and Provides Business Updates
Sep 25 2025
Rallybio Completes Dosing of First Cohort in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study

Financials

Revenue
$858 K
Market Cap
$44.59 M
EPS
-1.59

Community Chat

Ask AI

6ix6ixAIEvents